Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Carolina Wellness News.
Press releases published on July 15, 2025

Ozwell First to Achieve Drummond pDSI-Risk Certification for AI-Powered Health IT
DURHAM, NC, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Drummond, a trusted leader in health IT certification and compliance, is pleased to announce that Ozwell (a Medical Informatics Engineering, Inc. product), an innovator in ambient clinical …

Capstone Health Alliance and WellLink (Formerly CHAMPS) Group Purchasing Renew 10-Year Strategic Partnership
Together Delivering Aggregation Power and Supply Chain Savings to Members ASHEVILLE, NC, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Capstone Health Alliance and WellLink Group Purchasing (formerly CHAMPS Group Purchasing) are proud to announce …

Senior Dogs Fetch Lifesaving Grey Muzzle Grants
$1.57 Million in Grants Help Old Dogs Begin New Lives RALEIGH, NC, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- As animal shelters and rescue groups across the country face record numbers of homeless pets, there’s some heartening news for older …

New AI Leadership Upgrades Stop Supervisors From Leading the Wrong Way — Without IT
AI is quietly teaching your supervisors the wrong way to lead. New upgrades stop small mistakes from becoming company-wide nightmares — no IT needed. GREENSBORO, NC, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Call Center Coach today announced …

Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th
Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company …

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML
SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …

Gain Therapeutics Announces Proposed Public Offering
BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …

ADR Ratio Change
July 15, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the …

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue
AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, DuraPro™, as the …

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals
Combined Company to Trade on Nasdaq Under Ticker “IMA” Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) today announced the results of …

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LONDON …

Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025
FORT WORTH, TX, July 15, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce …

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025
CARLSBAD, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended June 30, 2025, before the market opens on Tuesday, July 29, 2025. John …

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results
KIRKLAND, Wash., July 15, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the fourth quarter and fiscal year ended April 30, 2025. …

Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States
BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced …

XLA Health Launches Modern Outsourcing Platform to Help Medical Practices Slash Administrative Overload
New York, NY, July 15, 2025 (GLOBE NEWSWIRE) -- XLA Health (www.xlahealth.com) officially rebrands its HIPAA-compliant outsourcing platform designed to relieve private‐practice physicians of the everyday administrative grind. By pairing college-educated, …

Tivity Health Appoints Natasha Deckmann as CEO
NASHVILLE, Tenn., July 15, 2025 (GLOBE NEWSWIRE) -- Tivity Health, a leading provider of healthy lifestyle solutions, including SilverSneakers®, Prime® Fitness, and WholeHealth Living®, announced today that Natasha Deckmann, M.D., has been named Chief …

BriaCell Therapeutics Announces Pricing of $15 million Public Offering
PHILADELPHIA and VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to …

Dr. Zachary Solomon Launches National Medical Tech Grant to Drive Healthcare Innovation Among U.S. Undergraduates
PHILADELPHIA, July 15, 2025 (GLOBE NEWSWIRE) -- Renowned cardiothoracic surgeon Dr. Zachary Solomon has officially announced the launch of the Dr. Zachary Solomon Medical Tech Grant, a prestigious academic initiative aimed at cultivating future leaders in …